Skip to main content

Pregnancy Outcomes in Japanese Patients with SLE: Retrospective Review of 55 Pregnancies at a University Hospital

Abstract

Systemic lupus erythematosus (SLE) is mainly a disease of fertile women and the coexistence of pregnancy is by no means a rare event. How SLE and its treatment affect pregnancy outcomes is still a matter of debate. We performed a retrospective analysis of 41 SLE patients (55 pregnancies) who were followed at our university hospital from January 2000 to December 2009. The mean age of patients was 30.6 ± 4.8 years and mean disease duration was 6.6 ± 5.3 years. After exclusion of artificial abortions, live birth rate was 84%. Significantly, more women with stillbirth pregnancies were complicated with antiphospholipid syndrome (APS) than women with live birth pregnancies (two of eight stillbirth pregnancies (25%) versus one of 42 live birth pregnancies (2%); p = 0.014) and hypocomplementemia at conception (four of eight stillbirth pregnancies (50%) versus six of 42 live birth pregnancies (14%); p = 0.021). Compared with nonrenal pregnancies, renal pregnancies were younger at SLE disease onset, had a lower positivity of anti-RNP antibody, and were more complicated with pregnancy-induced hypertension. Past maximum dose of prednisolone, the dose of prednisolone at conception, and percentage of past steroid pulse therapy were higher in renal pregnancies. Outcomes of pregnancies were not significantly different both for mothers and for infants between renal and nonrenal pregnancies. We conclude that it is necessary to provide SLE mothers with the proper information before pregnancy. Women with APS or hypocomplementemia should be regarded with particular attention. Optimal management of mothers and infants requires collaborative efforts of rheumatologists and obstetricians.

This is a preview of subscription content, access via your institution.

References

  1. Carvalheiras G, Vita P, Marta S et al (2010) Pregnancy and systemic lupus erythematosus: review of clinical features and outcome of 51 pregnancies at a single institution. Clin Rev Allergy Immunol 38:302–306

    PubMed  Article  Google Scholar 

  2. Boumpas DT, Austin HA 3rd, Vaughan EM, Yarboro CH, Klippel JH, Balow JE (1993) Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy. Ann Intern Med 119:366–369

    PubMed  CAS  Google Scholar 

  3. Andrade RM, McGwin G Jr, Alarcon GS et al (2006) Predictors of post-partum damage accrual in systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (XXXVIII). Rheumatol (Oxf) 45:1380–1384

    Article  CAS  Google Scholar 

  4. Moroni G, Ponticelli C (2005) Pregnancy after lupus nephritis. Lupus 14:89–94

    PubMed  Article  CAS  Google Scholar 

  5. Ruiz-Irastorza G, Khamashta MA (2009) Managing lupus patients during pregnancy. Best Pract Res Clin Rheumatol 23:575–582

    PubMed  Article  Google Scholar 

  6. Lockshin MD (1989) Pregnancy does not cause systemic lupus erythematosus to worsen. Arthritis Rheum 32:665–670

    PubMed  Article  CAS  Google Scholar 

  7. Nossent HC, Swaak TJ (1990) Systemic lupus erythematosus. VI. Analysis of the interrelationship with pregnancy. J Rheumatol 17:771–776

    PubMed  CAS  Google Scholar 

  8. Clowse ME (2007) Lupus activity in pregnancy. Rheum Dis Clin North Am 33:237–252

    PubMed  Article  Google Scholar 

  9. D’Cruz DP, Khamashta MA, Hughes GR (2007) Systemic lupus erythematosus. Lancet 369:587–596

    PubMed  Article  Google Scholar 

  10. Ruiz-Irastorza G, Khamashta MA (2004) Evaluation of systemic lupus erythematosus activity during pregnancy. Lupus 13:679–682

    PubMed  Article  CAS  Google Scholar 

  11. Fernandez M, Alarcon GS, Calvo-Alen J et al (2007) A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (sle) as a model for the study of ethnic disparities in sle. Arthritis Rheum 57:576–584

    PubMed  Article  Google Scholar 

  12. Hochberg MC (1997) Updating the american college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725

    PubMed  Article  CAS  Google Scholar 

  13. Gladman DD, Ibanez D, Urowitz MB (2002) Systemic lupus erythematosus disease activity index 2000. J Rheumatol 29:288–291

    PubMed  Google Scholar 

  14. Gladman DD, Urowitz MB, Kagal A, Hallett D (2000) Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheumatol 27:377–379

    PubMed  CAS  Google Scholar 

  15. Buyon JP, Clancy RM (2003) Neonatal lupus: review of proposed pathogenesis and clinical data from the us-based research registry for neonatal lupus. Autoimmunity 36:41–50

    PubMed  Article  CAS  Google Scholar 

  16. Mintz G, Niz J, Gutierrez G, Garcia-Alonso A, Karchmer S (1986) Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol 13:732–739

    PubMed  CAS  Google Scholar 

  17. Lockshin MD, Reinitz E, Druzin ML, Murrman M, Estes D (1984) Lupus pregnancy. Case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med 77:893–898

    PubMed  Article  CAS  Google Scholar 

  18. Urowitz MB, Gladman DD, Farewell VT, Stewart J, McDonald J (1993) Lupus and pregnancy studies. Arthritis Rheum 36:1392–1397

    PubMed  Article  CAS  Google Scholar 

  19. Petri M, Howard D, Repke J (1991) Frequency of lupus flare in pregnancy. The Hopkins Lupus Pregnancy Center experience. Arthritis Rheum 34:1538–1545

    PubMed  Article  CAS  Google Scholar 

  20. Ruiz-Irastorza G, Lima F, Alves J et al (1996) Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol 35:133–138

    PubMed  Article  CAS  Google Scholar 

  21. Wong KL, Chan FY, Lee CP (1991) Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch Intern Med 151:269–273

    PubMed  Article  CAS  Google Scholar 

  22. Tandon A, Ibanez D, Gladman DD, Urowitz MB (2004) The effect of pregnancy on lupus nephritis. Arthritis Rheum 50:3941–3946

    PubMed  Article  Google Scholar 

  23. Doria A, Tincani A, Lockshin M (2008) Challenges of lupus pregnancies. Rheumatol (Oxf) 47(Suppl 3):iii9–12

    Google Scholar 

  24. Tincani A, Bompane D, Danieli E, Doria A (2006) Pregnancy, lupus and antiphospholipid syndrome (Hughes syndrome). Lupus 15:156–160

    PubMed  Article  CAS  Google Scholar 

  25. Doria A, Ghirardello A, Iaccarino L et al (2004) Pregnancy, cytokines, and disease activity in systemic lupus erythematosus. Arthritis Rheum 51:989–995

    PubMed  Article  CAS  Google Scholar 

  26. Clark CA, Spitzer KA, Laskin CA (2005) Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol 32:1709–1712

    PubMed  Google Scholar 

  27. Zhang L, Abe K, Hashimoto H, Takasaki Y (2007) Pregnancy and fetal outcomes in patients with lupus nephritis. Nihon Rinsho Meneki Gakkai Kaishi 30:185–192

    PubMed  Article  CAS  Google Scholar 

  28. Kuroki M, Umekita K, Yamamoto M et al (2008) Clinical analysis of pregnant patients with systemic lupus erythematosus. Kyushu Journal of Rheumatology 28:23–27

    Google Scholar 

  29. Cavallasca JA, Laborde HA, Ruda-Vega H, Nasswetter GG (2008) Maternal and fetal outcomes of 72 pregnancies in argentine patients with systemic lupus erythematosus (SLE). Clin Rheumatol 27:41–46

    PubMed  Article  Google Scholar 

  30. Molad Y, Borkowski T, Monselise A et al (2005) Maternal and fetal outcome of lupus pregnancy: A prospective study of 29 pregnancies. Lupus 14:145–151

    PubMed  Article  CAS  Google Scholar 

  31. Clowse ME, Magder LS, Witter F, Petri M (2005) The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum 52:514–521

    PubMed  Article  Google Scholar 

  32. Nakamura Y (2010) Maternal and child health statistics in Japan. JMAJ 53(4):259–265

    Google Scholar 

  33. Aggarwal N, Raveendran A, Suri V, Chopra S, Sikka P, Sharma A (2010) Pregnancy outcome in systemic lupus erythematosus: Asia's largest single centre study. Arch Gynecol Obstet (in press)

  34. Clowse ME, Magder LS, Witter F, Petri M (2006) Early risk factors for pregnancy loss in lupus. Obstet Gynecol 107:293–299

    PubMed  Article  Google Scholar 

  35. Cervera R, Piette JC, Font J et al (2002) Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheum 46:1019–1027

    PubMed  Article  Google Scholar 

  36. Ziakas PD, Pavlou M, Voulgarelis M (2010) Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis. Obstet Gynecol 115:1256–1262

    PubMed  Article  Google Scholar 

  37. Erkan D, Patel S, Nuzzo M et al (2008) Management of the controversial aspects of the antiphospholipid syndrome pregnancies: a guide for clinicians and researchers. Rheumatol (Oxf) 47(Suppl 3):iii23–27

    Google Scholar 

  38. Imbasciati E, Tincani A, Gregorini G et al (2009) Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant 24:519–525

    PubMed  Article  Google Scholar 

  39. Shibata S, Sasaki T, Hirabayashi Y et al (1992) Risk factors in the pregnancy of patients with systemic lupus erythematosus: association of hypocomplementaemia with poor prognosis. Ann Rheum Dis 51:619–623

    PubMed  Article  CAS  Google Scholar 

  40. Cortes-Hernandez J, Ordi-Ros J, Paredes F, Casellas M, Castillo F, Vilardell-Tarres M (2002) Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatol (Oxf) 41:643–650

    Article  CAS  Google Scholar 

  41. Kobayashi N, Yamada H, Kishida T et al (1999) Hypocomplementemia correlates with intrauterine growth retardation in systemic lupus erythematosus. Am J Reprod Immunol 42:153–159

    PubMed  Article  CAS  Google Scholar 

  42. Friedman DM, Kim MY, Copel JA et al (2008) Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR interval and Dexamethasone Evaluation (PRIDE) prospective study. Circulation 117:485–493

    PubMed  Article  Google Scholar 

  43. Cimaz R, Spence DL, Hornberger L, Silverman ED (2003) Incidence and spectrum of neonatal lupus erythematosus: a prospective study of infants born to mothers with anti-Ro autoantibodies. J Pediatr 142:678–683

    PubMed  Article  Google Scholar 

  44. Brucato A, Frassi M, Franceschini F et al (2001) Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 44:1832–1835

    PubMed  Article  CAS  Google Scholar 

  45. Gu YH, Harada S, Kato T, Inomata H, Aoki K, Hirahara F (2009) Increased incidence of extrathyroidal congenital malformations in Japanese patients with congenital hypothyroidism and their relationship with Down syndrome and other factors. Thyroid 19:869–879

    PubMed  Article  Google Scholar 

  46. Gladman DD, Tandon A, Ibanez D, Urowitz MB (2010) The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J Rheumatol 37:754–758

    PubMed  Article  Google Scholar 

  47. Rahman FZ, Rahman J, Al-Suleiman SA, Rahman MS (2005) Pregnancy outcome in lupus nephropathy. Arch Gynecol Obstet 271:222–226

    PubMed  Article  Google Scholar 

  48. Soubassi L, Haidopoulos D, Sindos M et al (2004) Pregnancy outcome in women with pre-existing lupus nephritis. J Obstet Gynaecol 24:630–634

    PubMed  Article  CAS  Google Scholar 

  49. Alba P, Bento L, Cuadrado MJ et al (2003) Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis. Ann Rheum Dis 62:556–560

    PubMed  Article  CAS  Google Scholar 

  50. Cervera R, Khamashta MA, Font J et al (1993) Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore) 72:113–124

    CAS  Google Scholar 

  51. Reichlin M, Van Venrooij WJ (1991) Autoantibodies to the URNP particles: relationship to clinical diagnosis and nephritis. Clin Exp Immunol 83:286–290

    PubMed  Article  CAS  Google Scholar 

  52. Mackillop LH, Germain SJ, Nelson-Piercy C (2007) Systemic lupus erythematosus. BMJ 335:933–936

    PubMed  Article  Google Scholar 

Download references

Competing Interests

The authors have received no financial support or other benefits from commercial sources for the work reported here, and the authors have no other financial interests that could create a potential conflict of interest or the appearance of a conflict of interest with regard to the present study.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Haruko Ideguchi.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ideguchi, H., Ohno, S., Uehara, T. et al. Pregnancy Outcomes in Japanese Patients with SLE: Retrospective Review of 55 Pregnancies at a University Hospital. Clinic Rev Allerg Immunol 44, 57–64 (2013). https://doi.org/10.1007/s12016-011-8269-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-011-8269-8

Keywords

  • Systemic lupus erythematosus
  • Pregnancy
  • Antiphospholipid syndrome
  • Hypocomplementemia
  • Nephritis